Pfizer (PFE) and BioNTech's Omicron JN.1-adapted COVID-19 vaccine gets the Committee for Medicinal Products for Human Use's positive opinion recommending marketing authorization.
Pfizer appears to be on its way toward stabilizing its business and winning back Wall Street's favor after the sudden decline of its Covid business. But the company is struggling to balance that with

Is Pfizer Stock a Buy?

06:30am, Friday, 28'th Jun 2024
Pfizer shares have suffered a painful slide as pandemic revenue dried up. But management is committed to maintaining and growing the dividend.
A rare-disease drugmaker and a top pharmaceutical stock have what it takes to deliver solid returns over the long run. Vertex Pharmaceuticals' flagship business continues to expand market share and pr
The board of directors of AT&T today declared a quarterly dividend of $0.2775 per share on the company's common shares. Dividends on the common stock are payable on August 1, 2024, to stockholders of
The pharmaceutical market is a critical part of the healthcare industry. It contributes largely to research, development, production and distribution of important life-saving vaccines and medications.
It's not all about chasing the red-hot AI trade. Some value investors want solid dividend payouts that have the means to grow at a steady and relatively predictable rate over time.

This Recent FDA Approval Is Bad News for Pfizer

10:45am, Thursday, 27'th Jun 2024
Pfizer dominates the pneumococcal vaccine market. However, Merck has obtained approval for a pneumococcal vaccine Merck's new medication could become the new top seller for this indication.
NEW YORK and MAINZ, Germany, June 27, 2024 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human

2 Exceptional Growth Stocks to Buy for Under $100

09:15am, Thursday, 27'th Jun 2024
When a stock is trading on sale, it's important to understand why. Despite its post-pandemic slump, the long-term picture remains bright for Pfizer.
Markets hit new highs with Nasdaq up 0.08% and S&P 500 up 0.68%. Dividend Harvesting Portfolio adds $89.68 in profitability, projecting future growth. Portfolio generates $1,540.02 in forward dividend
Are stocks set to rip higher in the second half of 2024? Or will investors be in for a nasty October surprise?
A handful of top performers led to big gains for the major market indexes, but a couple of top dividend stocks didn't participate in the rally. Pfizer shares have been beaten down far enough that they

2 Stocks Down More Than 30% to Buy Right Now

04:27am, Thursday, 27'th Jun 2024
Moderna recently won approval for a second product -- one with a $10 billion market. Pfizer offers a juicy dividend yield and better growth prospects than you might think.

Pfizer Declares Third-Quarter 2024 Dividend

04:30pm, Wednesday, 26'th Jun 2024
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 third-quarter 2024 dividend on the company's common stock, payable September 3, 2024, to
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE